Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sysco Becomes Official Partner of the MICHELIN Guide Texas Ceremony
-
iMD Companies and Its Subsidiary Riize Health Announce Official Product Line Launch of Riize Hair
-
MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters
-
Clip Money Inc. Expands Partnership with CBL Properties to Bring On-Site Cash Deposit Services to 36 Malls
-
LiveOne (Nasdaq: LVO) Reports Q2 Fiscal 2025 Results
-
Aventon Ranked #1 in the TIME World’s Best Brands 2024
-
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
-
Breaking Barriers: New Explainer on the Science of Addiction Available in 12 Languages
-
Armlogi Announces New 480,000 Square Foot Warehouse Lease in Ontario, CA
-
Annual International Conference on ADHD Hosted by CHADD, ADDA and ACO Provides Trusted Information, Guidance and Support to the ADHD Community
-
Los Angeles County Adds Genasys ALERT Emergency Warning and Notification to Genasys EVAC Emergency Management and Planning
-
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
-
Spur Therapeutics to Participate in B. Riley Securities’ Next-Gen Tissue Delivery Modalities Virtual Summit
-
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Sunrise Realty Trust Announces the Successful Closing of a Senior Revolving Credit Facility up to $200 Million with an Initial $50 Million Commitment from East West Bank
-
Regency Centers Increases Common Stock Dividend by 5.2%
-
Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024
-
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Duos Edge AI Acquires Additional Edge Data Centers
-
Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
-
Better Choice Company to Present at the Sidoti Micro Cap 2024 Virtual Conference
-
Skyharbour Commences Fall Diamond Drilling Program at its Russell Lake Uranium Project, Saskatchewan
-
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
-
Absci to Host R&D Day on December 12, 2024
-
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
-
Cassava Sciences Reports Q3 2024 Financial and Operating Results
-
Vericel Reports Third Quarter 2024 Financial Results
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
Waterfall Network Becomes the Most Scalable EVM-based Smart Contract Platform According to Recent Performance Tests
-
ParaZero Secured $187,000 Purchase Order for Cutting-Edge Drone Safety Systems, Moving Closer to Mass-Production
-
Next Hydrogen to demonstrate electrolyzers for the aviation industry in collaboration with Pratt & Whitney under INSAT program
-
Next Hydrogen to demonstrate electrolyzers for the aviation industry in collaboration with Pratt & Whitney under INSAT program
-
Company Distilling Unveils Ghost Rail Heirloom Gin, Bringing a Unique Spirit to Both Gin and Whiskey Lovers Alike
-
R3’s Corda selected as first authorized DLT platform for European DLT Pilot Regime
-
Sunrise Realty Trust, Inc. Announces Financial Results for Third Quarter 2024
-
Alliance Witan PLC - Net Asset Value
-
Angus Gold to Present at the 2024 Precious Metals Summit Zurich and Participate in the 121 Mining Investment Conference
-
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
-
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Condor to Present Its Energy Transition Initiatives at COP29 in Baku, Azerbaijan
-
Knight Therapeutics Reports Third Quarter 2024
-
Kelly Reports Third-Quarter 2024 Earnings
-
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
-
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
-
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
-
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
